Nephrologist who likes to visit the ICU. Works at @OttawaRenal. PI for @AlterAKItrial.

Ottawa, Canada
Joined March 2017
Edward (Ted) Clark MD MSc retweeted
Excited to see this finally in press!!! Shout-out to coauthors @hswapnil @intensivistAk @OleksaRewa @edclark75 and to @EtienneMacedo and @RavindraLMehta1 whose prior version we built upon. @AJKDonline #nephCC #nephcrit #critcareneph #AKI sciencedirect.com/science/ar…
5
12
1,329
Edward (Ted) Clark MD MSc retweeted
🎉Congratulations, Dr. @coryegoldstein! Winner of @uOttawa Faculty of Medicine's Best Paper Award 2024 for "The Ottawa Statementment implementation guidance document for cluster randomized trials in hemodialysis setting". Find more about it @ rebrand.ly/mz8ej8e
1
6
634
Happening this Thursday! Dr Emily See presenting on AKI: Contemporary concepts and personalized care #NephGR at @UOttawaMed
1
9
1
43
3,772
We start the fall season of #NephGR tomorrow with our former @OttawaRenal fellow Adrianna Douvris who is now a PDF in the Stanford lab at OHRI Note switch from MS Teams to Zoom!
2
3
17
1,912
Edward (Ted) Clark MD MSc retweeted
ALTER-AKI Trial hit a major milestone this week with our 100th participant enrolled! @CCCTG_ @CNTN_RCEN #CTTG
3
6
1,072
beautifully written 10/12 guideline statements are: albumin is NOT recommended/suggested @edclark75 et al to complete @AlterAKItrial to inform some (one) of these issues h/t @PulmCrit
Review the latest guidance from the International Collaboration for Transfusion Medicine Guidelines on the use of intravenous albumin in the August @journal_CHEST issue: hubs.la/Q02KHPC90 #MedEd #MedTwitter
7
29
3,776
Edward (Ted) Clark MD MSc retweeted
Congrats to @lakeridgehealth critical care doc @shanfernands as lead author on this systematic review of the role of methylene blue in septic shock! Great team of investigators that will continue to work on better understanding of this therapy. journals.lww.com/ccejournal/…
6
8
853
Edward (Ted) Clark MD MSc retweeted
Best retrospective #POCUS study: Gaudreau-Simard M et al. Test characteristics of POCUS in patients with acute kidney injury. Ultrasound J 2024;16:15. @MathildeGSimard @uOttawamwoo @sydneyruller @epi_rad @edclark75 @krw127 🔗doi.org/10.1186/s13089-023-0…
1
3
1
5
912
Congrats to @DSchnekenB for being appointed as the Associate Program Director at the Inflammation/Chronic Disease for @OttawaHospital OHRI!
1
1
13
3,039
Edward (Ted) Clark MD MSc retweeted
Congrats to the @KingstonHSC @queensccm team for enrolling their 1st patient into @AlterAKItrial!! @HanleyMichaela @jgordonboyd @jeanniecallum @drsamsilver @docsibley @muscedej @CCCTG_ @CNTN_RCEN #CTTG
3
7
703
Edward (Ted) Clark MD MSc retweeted
Kudos to the ICU research team @niagarahealth for randomizing their first patient into the ALTER-AKI trial this past week! @JenniferTsang12 @CCIRNet @CCCTG_ @CNTN_RCEN #CTTG
2
7
364
So far it has been @mcgillu (2021) @queensu (2022) and @UofTNephrology (2023) to be the Canadian Program with top #Nephmadness scores and bragging rights! Who will it be this year?
1
5
14
3,068
Edward (Ted) Clark MD MSc retweeted
Sharing our latest work characterizing CHIP as a risk factor for acute kidney injury (AKI) using human cohort data and mouse models. Published today in @NatureMedicine: nature.com/articles/s41591-0…
16
33
3
123
23,248
We are excited to host @VelezNephHepato from @OchsnerNephro in person this week at @OttawaRenal @KRC_Events @UOttawa #NephGR tomorrow
4
5
1
53
9,801
Happening tomorrow! Dr Fawad Qureshi from @MayoClinicNeph will be presenting at @OttawaRenal #NephGR on dialysis access
3
5
1
25
6,509
Edward (Ted) Clark MD MSc retweeted
Last week was a big one for ALTER-AKI: received great news from @CIHR_IRSC AND first participants at @HeartInstitute were enrolled by all-star coordinator #RebeccaPorteous.
2
6
358
Edward (Ted) Clark MD MSc retweeted
1/3 We are excited to announce that the ALTER-AKI trial has been funded by @CIHR_IRSC! This will allow for the trial to be expanded, and completed, across🇨🇦. @CCCTG_ @CNTN_RCEN #CTTG @CCIRNet @edclark75 @JeannieCallum @DrRonWald @DrSeanBagshaw
2
9
27
4,409